Search

Merck KGaA

Suletud

SektorTervishoid

114.95 -0.3

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

114.4

Max

114.95

Põhinäitajad

By Trading Economics

Sissetulek

-83M

652M

Müük

-25M

5.3B

Aktsiakasum

2.07

Dividenditootlus

1.34

Kasumimarginaal

12.407

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+22.55% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.34%

2.33%

Järgmine tulemuste avaldamine

13. nov 2025

Turustatistika

By TradingEconomics

Turukapital

98B

Eelmine avamishind

115.25

Eelmine sulgemishind

114.95

Uudiste sentiment

By Acuity

19%

81%

29 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Merck KGaA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. okt 2025, 08:54 UTC

Suurimad hinnamuutused turgudel

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

7. aug 2025, 05:43 UTC

Tulu

Germany's Merck Raises Earnings Growth Guidance, But Turns Cautious on Sales

16. okt 2025, 08:34 UTC

Market Talk

Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk

15. okt 2025, 12:08 UTC

Omandamised, ülevõtmised, äriostud

Merck KGaA Didn't Disclose Financial Details

15. okt 2025, 12:07 UTC

Omandamised, ülevõtmised, äriostud

Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio

15. okt 2025, 12:07 UTC

Omandamised, ülevõtmised, äriostud

Merck KGaA: Unit is Based in Belgium, Has 50+ Employees

15. okt 2025, 12:06 UTC

Omandamised, ülevõtmised, äriostud

Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market

15. okt 2025, 12:05 UTC

Omandamised, ülevõtmised, äriostud

Merck KGaA: Definitive Agreement Signed Today

15. okt 2025, 12:05 UTC

Omandamised, ülevõtmised, äriostud

Merck KGaA: Transaction Expected to Close by End of 2Q 2026

15. okt 2025, 12:04 UTC

Omandamised, ülevõtmised, äriostud

Merck KGaA to Buy Chromatography Business JSR Life Sciences

15. okt 2025, 12:03 UTC

Omandamised, ülevõtmised, äriostud

Merck KGaA to Buy Chromatography Business of JSR Life Sciences

7. aug 2025, 08:04 UTC

Market Talk
Tulu

Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Had Seen 2025 Group Ebitda Before Exceptional Items of EUR5.8B-EUR6.4B

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Had Guided for 2025 Group Sales of EUR20.9B-EUR22.4B

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Had Seen 2025 Organic Growth in Ebitda Before Exceptional Items at 2%-7%

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Had Guided for 2025 Organic Sales Growth at 2%-6%

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Now Sees 2025 Group Ebitda Before Exceptional Items of EUR5.9B-EUR6.3B

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Now Sees 2025 Organic Growth in Ebitda Before Exceptional Items at 4%-8%

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Cuts 2025 View To Sales EUR20.5B-EUR21.7B

7. aug 2025, 05:00 UTC

Tulu

Analysts Saw Merck KGaA 2Q Sales at EUR5.32B

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Now Expects 2025 Organic Sales Growth at 2%-5%

7. aug 2025, 05:00 UTC

Tulu

Analysts Saw Merck KGaA 2Q Ebitda Before Exceptional Items at EUR1.52B

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Says It Faced Strong Currency Headwinds

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Adjusts 2025 View

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Raises 2025 Guidance for Organic Growth in Ebitda Before Exceptional Items

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA Narrows 2025 Organic Sales Growth Guidance

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA 2Q EBITDA EUR1.35B

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA 2Q After-Tax Profit EUR655M

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA 2Q Sales EUR5.255B

7. aug 2025, 05:00 UTC

Tulu

Merck KGaA 2Q Ebitda Before Exceptional Items EUR1.46B

Merck KGaA Prognoos

Hinnasiht

By TipRanks

22.55% tõus

12 kuu keskmine prognoos

Keskmine 140.99 EUR  22.55%

Kõrge 182 EUR

Madal 115.9 EUR

Põhineb 9 Wall Streeti analüütiku instrumendi Merck KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

9 ratings

6

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

121.15 / 123.55Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Neutral Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

29 / 371 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Merck KGaA

There is no Profile data available for MRK.BE.
help-icon Live chat